Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?

Blood cancer discovery·2026
Same author

A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial.

Cancers·2026
Same author

Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.

Nature immunology·2026
Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Blood·2026
Same author

Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell Lymphoma.

Cancer medicine·2026
Same author

OSTM1 is a ubiquitin E3 ligase that suppresses B-cell malignancy by activating the cAMP/PKA/CREB pathway.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Dec 23, 2025

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

7.1K

HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.

Marco De Martino1, Davide De Biase2, Floriana Forzati1

  • 1Istituto di Endocrinologia ed Oncologia Sperimentale - CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Naples, Italy.

Scientific Reports
|April 29, 2020
PubMed
Summary

Cancer-promoting HMGA1 pseudogenes were studied. Overexpression of HMGA1P7 in mice led to B-cell lymphoma, demonstrating their in vivo oncogenic activity and potential as cancer biomarkers.

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.7K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Related Experiment Videos

Last Updated: Dec 23, 2025

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
09:35

Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches

Published on: April 20, 2021

7.1K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.7K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The HMGA1 gene plays a critical role in cancer progression.
  • HMGA1 pseudogenes (HMGA1P6, HMGA1P7) function as microRNA decoys, upregulating cancer-related genes.
  • These pseudogenes are upregulated in human carcinomas, correlating with poor prognosis.

Purpose of the Study:

  • To investigate the in vivo oncogenic activity of HMGA1 pseudogenes.
  • To generate a transgenic mouse model for studying HMGA1P7 function.

Main Methods:

  • Generation of a HMGA1P7 transgenic mouse line.
  • Analysis of tumor development, including flow cytometry (FACS), immunohistochemistry, clonality assays, and RNA expression profiling.

Main Results:

  • Approximately 50% of HMGA1P7 transgenic mice developed splenomegaly and lymphoid cell accumulation by 12 months.
  • Pathological analyses indicated B-cell lymphoma in affected mice.
  • Clonality and RNA expression profiles supported the diagnosis of B-cell lymphoma.

Conclusions:

  • HMGA1 pseudogenes exhibit clear oncogenic activity in vivo.
  • HMGA1P7 overexpression can drive B-cell lymphoma development.
  • These findings highlight the role of pseudogenes in cancer and their potential as therapeutic targets or biomarkers.